Description

Cyclopropanecarboxamide, n-[(2-Chloro-8-Methyl-3-Quinolinyl)Methyl]-n-(Phenylmethyl)- (9Ci) is a high-purity, specialized organic compound identified by CAS No. 606095-27-6. This compound serves as a critical advanced pharmaceutical intermediate or research chemical for the development of novel active ingredients. It is primarily required by pharmaceutical R&D and fine chemical synthesis sectors for creating targeted therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in oncology and antiviral research.
• Chemical Research: Used in academic and industrial laboratories for studying structure-activity relationships (SAR) and developing new chemical entities.
• Agrochemical Development: Potential intermediate for creating advanced crop protection agents and pesticides.
• Material Science Research: Serves as a precursor for specialized polymers or organic electronic materials due to its complex quinoline-based structure.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Reference Standard: Utilized as a high-purity analytical standard for quality control and method development in analytical laboratories.

Basic Information

Product Name	Cyclopropanecarboxamide, n-[(2-Chloro-8-Methyl-3-Quinolinyl)Methyl]-n-(Phenylmethyl)- (9Ci)
CAS No.	606095-27-6
Molecular Formula	C22H21ClN2O
Molecular Weight	364.87 g/mol
Synonyms	N-[(2-Chloro-8-methylquinolin-3-yl)methyl]-N-benzylcyclopropanecarboxamide; N-Benzyl-N-[(2-chloro-8-methyl-3-quinolinyl)methyl]cyclopropanecarboxamide; Cyclopropanecarboxamide, N-[(2-chloro-8-methyl-3-quinolinyl)methyl]-N-(phenylmethyl)-; UNII-8J4Z9K6K3F; 8J4Z9K6K3F; BDBM50391485; AKOS025310991; ZINC000103014777
EINECS	Contact for details

Quality Control

Every batch of Cyclopropanecarboxamide, n-[(2-Chloro-8-Methyl-3-Quinolinyl)Methyl]-n-(Phenylmethyl)- (9Ci) undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our quality assurance protocols are designed to meet the stringent requirements of pharmaceutical intermediate supply. A comprehensive Certificate of Analysis (COA) detailing purity (typically ≥95% by HPLC), identity confirmation, and impurity profiles is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Any single unknown impurity	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.